Kimberly Gentile
Chief Tech/Sci/R&D Officer en BIOHAVEN LTD. .
Fortuna: 5 M $ al 31/03/2024
Perfil
La Sra. Kimberly Gentile es Vicepresidenta Senior de Operaciones Clínicas en Biohaven Pharmaceutical Holding Co. Ltd. y Directora de Operaciones de Portage Pharmaceutical Ltd. Anteriormente, la Sra. Gentile trabajó como Directora Asociada en Bristol Myers Squibb Co. y como Directora Senior de Operaciones Clínicas en SCIREX Corp. Se licenció en la Universidad Estatal de Salem.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOHAVEN LTD.
0.12% | 04/03/2024 | 95 969 ( 0.12% ) | 5 M $ | 31/03/2024 |
Cargos activos de Kimberly Gentile
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Chief Operating Officer | - |
Antiguos cargos conocidos de Kimberly Gentile.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | 03/10/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/02/2014 |
| SCIREX Corp. | Corporate Officer/Principal | 01/06/2000 |
Formación de Kimberly Gentile.
| Salem State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Empresas privadas | 3 |
|---|---|
| SCIREX Corp. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
- Bolsa de valores
- Insiders
- Kimberly Gentile
